Sign up to save your podcasts
Or
Share Moderna’s Rise, JCP’s Split
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Moderna’s Rise, JCP’s Split
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
More shows like MarketFoolery
View all
Motley Fool Hidden Gems Investing
3,217 Listeners
InvestTalk
1,482 Listeners
Motley Fool Answers
808 Listeners
Rule Breaker Investing
944 Listeners
Investing Insights
521 Listeners
Bloomberg Surveillance
1,170 Listeners
Masters in Business
2,201 Listeners
Industry Focus
825 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,422 Listeners
Wall Street Breakfast
1,038 Listeners
The Best One Yet
9,715 Listeners
Chit Chat Stocks
195 Listeners
Ready For Retirement
833 Listeners
The Canadian Investor
84 Listeners
Early Retirement - Financial Freedom (Investing, Tax Planning, Retirement Strategy, Personal Finance)
584 Listeners
The Psychology of Money with Morgan Housel
1,049 Listeners
Stock Market Today With IBD
56 Listeners